Literature DB >> 22426119

The potential of stem cell therapy for stroke: is PISCES the sign?

Helen K Smith1, Felicity N E Gavins.   

Abstract

Substantial developments in the field of stem cell research point toward novel therapies for the treatment of diseases such as stroke. This review covers the establishment of tissue damage in stroke and the status of current therapies. We evaluate stem cell therapy with respect to other treatments, including clinical, preclinical, and failed, and provide a comprehensive account of stem cell clinical trials for stroke therapy currently underway. Finally, we describe mechanisms through which stem cells improve outcome in experimental stroke as well as potential pitfalls this basic research has identified.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22426119     DOI： 10.1096/fj.11-195719

Source DB:  PubMed          Journal:  FASEB J        ISSN： 0892-6638            Impact factor:   5.191


  20 in total

1.  Strategies for early stroke recovery: what lies ahead?

Authors:  Tomoko Kitago; Randolph S Marshall
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-01

Review 2.  Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.

Authors:  Yao-Hui Tang; Yuan-Yuan Ma; Zhi-Jun Zhang; Yong-Ting Wang; Guo-Yuan Yang
Journal:  CNS Neurosci Ther       Date:  2015-02-10       Impact factor: 5.243

Review 3.  Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells.

Authors:  Antoine Monsel; Ying-Gang Zhu; Stephane Gennai; Qi Hao; Jia Liu; Jae W Lee
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

4.  Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.

Authors:  Shantel A Vital; Felix Becker; Paul M Holloway; Janice Russell; Mauro Perretti; D Neil Granger; Felicity N E Gavins
Journal:  Circulation       Date:  2016-05-06       Impact factor: 29.690

Review 5.  Cell based therapies for ischemic stroke: from basic science to bedside.

Authors:  Xinfeng Liu; Ruidong Ye; Tao Yan; Shan Ping Yu; Ling Wei; Gelin Xu; Xinying Fan; Yongjun Jiang; R Anne Stetler; George Liu; Jieli Chen
Journal:  Prog Neurobiol       Date:  2013-12-12       Impact factor: 11.685

6.  Physiologically normal 5% O2 supports neuronal differentiation and resistance to inflammatory injury in neural stem cell cultures.

Authors:  Xiaoyun Sun; Ludmila A Voloboueva; Creed M Stary; Rona G Giffard
Journal:  J Neurosci Res       Date:  2015-07-03       Impact factor: 4.164

7.  Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke.

Authors:  Helen K Smith; Seiichi Omura; Shantel A Vital; Felix Becker; Elena Y Senchenkova; Gaganpreet Kaur; Ikuo Tsunoda; Shayn M Peirce; Felicity N E Gavins
Journal:  FASEB J       Date:  2017-12-21       Impact factor: 5.191

8.  Neuroprotective effects of systemic cerebral endothelial cell transplantation in a rat model of cerebral ischemia.

Authors:  Jong-Hyun Moon; Joo-Young Na; Min-Cheol Lee; Kang-Ho Choi; Jeong-Kil Lee; Jung-Joon Min; Kyung-Tae Kim; Jong-Tae Park; Man-Seok Park; Hyung-Seok Kim
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 9.  Progress in stem cell therapy for major human neurological disorders.

Authors:  P L Martínez-Morales; A Revilla; I Ocaña; C González; P Sainz; D McGuire; I Liste
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

10.  Neural precursor cells cultured at physiologically relevant oxygen tensions have a survival advantage following transplantation.

Authors:  Sybil R L Stacpoole; Daniel J Webber; Bilada Bilican; Alastair Compston; Siddharthan Chandran; Robin J M Franklin
Journal:  Stem Cells Transl Med       Date:  2013-05-15       Impact factor: 6.940
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.